Literature DB >> 11443005

Human genetic adaptation to high altitude.

L G Moore1.   

Abstract

Some 140 million persons live permanently at high altitudes (>2500 m) in North, Central and South America, East Africa, and Asia. Reviewed here are recent studies which address the question as to whether genetic adaptation to high altitude has occurred. Common to these studies are the use of the oxygen transport system and the passage of time as organizing principles, and the recognition of the multifaceted ways in which genetic factors can influence physiological processes. They differ in terms of study approach and sources of evidence for judging duration of high altitude residence. Migrant, family set, and admixture study designs have been used for comparisons within populations. These collectively demonstrate the existence of genetic influences on physiological characteristics of oxygen transport. Differences in oxygen transport-related traits between Tibetan, Andean and European populations have been interpreted as having demonstrated the existence of genetic influences on high altitude adaptation but there is not consensus as to which groups are the best-adapted. Part of the controversy lies in the kinds of evidence used to assess duration of high altitude habitation. More other information is needed for a fuller appreciation of duration of residence and also features of population history (genetic drift, gene flow) but existing data are consistent with Tibetans having lived at high altitude longer than the other groups studied. Another issue surrounds usage of the term "adaptation." The definition should be based on evolutionary biology and physiological traits linked to indices of differential fertility and/or mortality. Two examples are developed to illustrate such linkages; intrauterine growth restriction (IUGR) at high altitude and the prevalence of Chronic Mountain Sickness (CMS). Interpopulational as well as intrapopulational variation exists in these conditions which appear linked to characteristics of oxygen transport. Both adversely influence survival and appear to be less severe (IUGR) or less common (CMS) among Tibetans than other groups. Thus available evidence suggest that Tibetans are better adapted. Needed, however, are studies which are better controlled for population ancestry, especially in South America, to determine the extent to which Tibetans differ from Andean highlanders. More precise information is also needed regarding the genetic factors underlying characteristics of oxygen transport. Such studies in Tibetan, Andean and Europeans as well as other high altitude populations offers a promising avenue for clarifying the adaptive value of physiological components of oxygen transport and the extent to which such factors differ among high altitude populations.

Entities:  

Mesh:

Year:  2001        PMID: 11443005     DOI: 10.1089/152702901750265341

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  92 in total

1.  Second generation Tibetan lowlanders acclimatize to high altitude more quickly than Caucasians.

Authors:  Claudio Marconi; Mauro Marzorati; Bruno Grassi; Buddha Basnyat; Angelo Colombini; Bengt Kayser; Paolo Cerretelli
Journal:  J Physiol       Date:  2004-02-06       Impact factor: 5.182

Review 2.  Phenotypic plasticity and genetic adaptation to high-altitude hypoxia in vertebrates.

Authors:  Jay F Storz; Graham R Scott; Zachary A Cheviron
Journal:  J Exp Biol       Date:  2010-12-15       Impact factor: 3.312

3.  AKT3, ANGPTL4, eNOS3, and VEGFA associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau.

Authors:  Norman E Buroker; Xue-Han Ning; Zhao-Nian Zhou; Kui Li; Wei-Jun Cen; Xiu-Feng Wu; Wei-Zhong Zhu; C Ronald Scott; Shi-Han Chen
Journal:  Int J Hematol       Date:  2012-06-24       Impact factor: 2.490

Review 4.  Genetic determinants of Tibetan high-altitude adaptation.

Authors:  Tatum S Simonson; Donald A McClain; Lynn B Jorde; Josef T Prchal
Journal:  Hum Genet       Date:  2011-11-09       Impact factor: 4.132

5.  Reexamination of hemoglobin adjustments to define anemia: altitude and smoking.

Authors:  Andrea J Sharma; O Yaw Addo; Zuguo Mei; Parminder S Suchdev
Journal:  Ann N Y Acad Sci       Date:  2019-06-23       Impact factor: 5.691

6.  Whole-genome sequencing uncovers the genetic basis of chronic mountain sickness in Andean highlanders.

Authors:  Dan Zhou; Nitin Udpa; Roy Ronen; Tsering Stobdan; Junbin Liang; Otto Appenzeller; Huiwen W Zhao; Yi Yin; Yuanping Du; Lixia Guo; Rui Cao; Yu Wang; Xin Jin; Chen Huang; Wenlong Jia; Dandan Cao; Guangwu Guo; Jorge L Gamboa; Francisco Villafuerte; David Callacondo; Jin Xue; Siqi Liu; Kelly A Frazer; Yingrui Li; Vineet Bafna; Gabriel G Haddad
Journal:  Am J Hum Genet       Date:  2013-08-15       Impact factor: 11.025

7.  LINE-1 and EPAS1 DNA methylation associations with high-altitude exposure.

Authors:  Ainash Childebayeva; Tamara R Jones; Jaclyn M Goodrich; Fabiola Leon-Velarde; Maria Rivera-Chira; Melisa Kiyamu; Tom D Brutsaert; Dana C Dolinoy; Abigail W Bigham
Journal:  Epigenetics       Date:  2019-01-09       Impact factor: 4.528

8.  Effect of altitude on brain intracellular pH and inorganic phosphate levels.

Authors:  Xian-Feng Shi; Paul J Carlson; Tae-Suk Kim; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Seong-Eun Kim; Breanna Glaeser; Kristina Wang; Chun S Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Psychiatry Res       Date:  2014-04-13       Impact factor: 3.222

Review 9.  Measuring high-altitude adaptation.

Authors:  Lorna G Moore
Journal:  J Appl Physiol (1985)       Date:  2017-08-31

10.  Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data.

Authors:  Abigail Bigham; Marc Bauchet; Dalila Pinto; Xianyun Mao; Joshua M Akey; Rui Mei; Stephen W Scherer; Colleen G Julian; Megan J Wilson; David López Herráez; Tom Brutsaert; Esteban J Parra; Lorna G Moore; Mark D Shriver
Journal:  PLoS Genet       Date:  2010-09-09       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.